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SUMMARY
Genetic studies have revealed significant overlaps of risk genes among psychiatric disorders. 
However, it is not clear how different mutations of the same gene contribute to different disorders. 
We characterized two lines of mutant mice with Shank3 mutations linked to ASD and 
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schizophrenia. We found both shared and distinct synaptic and behavioral phenotypes. Mice with 
the ASD-linked InsG3680 mutation manifest striatal synaptic transmission defects before weaning 
age and impaired juvenile social interaction, coinciding with the early onset of ASD symptoms. 
On the other hand, adult mice carrying the schizophrenia-linked R1117X mutation show profound 
synaptic defects in prefrontal cortex and social dominance behavior. Furthermore, we found 
differential Shank3 mRNA stability and SHANK1/2 upregulation in these two lines. These data 
demonstrate that different alleles of the same gene may have distinct phenotypes at molecular, 
synaptic, and circuit levels in mice, which may inform exploration of these relationships in human 
patients.
INTRODUCTION
Although schizophrenia and autism are two different disorders (DSM-5), it has long been 
proposed that they share some common pathologies and symptoms (de Lacy and King, 
2013). Currently, the etiologies of schizophrenia and autism are largely unknown, but recent 
human studies highlight the contribution of genetic risk factors to both disorders 
(Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014; De Rubeis 
et al., 2014). In particular, mutations in a group of genes linked to synaptic development, 
function, and plasticity were frequently identified in patients diagnosed with either 
schizophrenia or autism (Kenny et al., 2014), suggesting that genetic mutations leading to 
dysregulation of synaptic transmission play critical roles in the pathophysiology of both 
disorders (De Rubeis et al., 2014; Fromer et al., 2014). Interestingly, recent genetic studies 
further revealed significant overlaps of risk genes across major psychiatric disorders 
including schizophrenia, bipolar disorder, major depressive disorder, and autism (Lee et al., 
2013; Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013). Furthermore, 
large-scale exome sequencing of autism spectrum disorder (ASD) and schizophrenia patient 
DNA samples has identified many of the same genes in both disorders, suggesting that 
different mutations in the same gene can cause/contribute to different disorders (Guilmatre 
et al., 2014; McCarthy et al., 2014).
One such example is the SHANK3 gene (Boeckers et al., 1999; Naisbitt et al., 1999). 
SHANK family members share five main domain regions: N-terminal ankyrin repeats, SH3 
domain, PDZ domain, proline-rich region, and a C-terminal SAM domain. Through these 
functional domains, SHANK interacts with many postsynaptic density (PSD) proteins. Most 
notably, SHANK binds to SAPAP, which in turn binds to PSD95 to form the PSD95/
SAPAP/SHANK postsynaptic complex (Kim and Sheng, 2004). Together, these three 
groups of multi-domain proteins are proposed to form a key scaffold, orchestrating the 
assembly of the macromolecular postsynaptic signaling complex at glutamatergic synapses. 
This complex has been shown to play an important role in targeting, anchoring, and 
dynamically regulating synaptic localization of neurotransmitter receptors and signaling 
molecules (McAllister, 2007). SHANK is also connected to the mGluR pathway through its 
binding to Homer (Tu et al., 1999). In addition, given its link to actin-binding proteins, 
SHANK has been shown to regulate spine development (Roussignol et al., 2005; Sala et al., 
2001).
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Deletion of SHANK3 has been shown to be the cause of core neurodevelopmental and 
neurobehavioral deficits in Phelan-McDermid syndrome (PMS), an autism spectrum 
disorder with symptoms that include intellectual disability, autistic behaviors, hypotonia, 
and impaired development of speech and language (Wilson et al., 2003). Subsequent genetic 
screens also identified a variety of mutations in the SHANK3 gene in ASD patients not 
diagnosed with PMS including a guanine nucleotide insertion in exon 21 of SHANK3 gene 
(position 3680) from two brothers diagnosed with ASD accompanied by severe mental 
retardation (Durand et al., 2007; Gauthier et al., 2009; Moessner et al., 2007). These data 
implicate SHANK3 gene disruption/mutation as a monogenic cause of ASD. In support of 
these genetic findings, studies of Shank3 mutant mice from our laboratory and others have 
revealed various degrees of synaptic dysfunction and autistic-like behaviors (Bozdagi et al., 
2010; Kouser et al., 2013; Peça et al., 2011; Wang et al., 2011b). In addition, duplication of 
the SHANK3 gene was found in patients diagnosed with bipolar disorders and mice with 
Shank3 overexpression exhibit synaptic dysfunction and manic-like phenotypes (Han et al., 
2013).
Interestingly, a non-sense mutation of SHANK3 changing an arginine to stop codon 
(R1117X) was identified from three brothers diagnosed with schizophrenia/schizoaffective 
disorder between ages 16 and 21 without showing obvious autistic features during their 
childhood (Gauthier et al., 2010). The three brothers also had mild-to-moderate mental 
retardation, which is often seen, and generally more severe, in ASD patients with SHANK3 
mutations. Understanding the mechanisms by which different mutations in the same gene 
lead to different disorders will likely shed light on both shared and unique neural 
mechanisms of these disorders. We therefore created two mutant mouse lines. The first line 
harbors the ASD patient-linked single guanine nucleotide (G) insertion at cDNA position 
3680 and leads to a frameshift and downstream stop codon (InsG3680 mutation). The 
second line contains the schizophrenia patient-linked point mutation and changes arginine 
1117 to a stop codon (R1117X mutation). We performed systematic comparisons between 
the two mutant lines at molecular, cellular, synaptic, and behavioral levels and found both 
distinct and shared defects in these two mutant models. In particular, we found that mutant 
mice with the ASD-linked InsG3680 mutation, but not with the schizophrenia-linked 
R1117X mutation, manifest defective synaptic transmission in the striatum before weaning 
age, as well as impaired juvenile social play behavior, coinciding with the early onset of 
ASD symptoms in human patients. On the other hand, adult mice with the R1117X 
mutation, but not with the InsG3680 mutation, show synaptic defects in prefrontal cortex, 
consistent with clinical findings implicating prefrontal cortex defects in schizophrenia 
patients. Biochemical studies revealed both common and differential defects in postsynaptic 
signaling complexes and differential compensatory mechanisms in these two mutant lines. 
Behaviorally, both lines of mutant mice exhibit anxiety-like behavior and social interaction 
deficits. However, InsG3680 mutant mice show stronger repetitive/compulsive grooming 
behavior, whereas R1117X mutant mice show stronger allogrooming and social dominance-
like behavior. Together, our study potentially provides a mechanistic explanation on how 
distinct mutations of the Shank3 gene may lead to distinct molecular, synaptic, and circuit 
defects and relevant behavior abnormalities.
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RESULTS
Distinct Effects of InsG3680 and R1117X Mutations on SHANK3 Protein and mRNA
Shank3 is a very complex gene at the transcript level because of multiple intragenic 
promotors and alternative splicing (Wang et al., 2011b; Wang et al., 2014b). Both InsG3680 
and R1117X mutations are in exon 21, which is common to most if not all isoforms, and the 
two mutations were separated by only 325 nucleotides (Figure 1A). For InsG3680 mutation, 
we placed the G insertion at position 3680 in Shank3, which causes a frameshift and a stop 
codon immediately after the G insertion (Figures 1A and 1B). For the R1117X mutation, we 
changed arginine (R) codon “CGG” to stop codon “TGA” to introduce the “R” to “X” 
mutation at amino acid position 1117 as described in the finding from schizophrenia patients 
(Figures 1A and 1B). We generated a C57 B6/S129 Sv mixed background mice population 
for all experiments performed in this study unless otherwise specified. Both homozygous 
InsG3680 and R1117X Shank3 mutant mice are viable and fertile.
The predicted sizes of the resulting truncated proteins are 135 kDa for InsG3680 mutation 
and 122 kDa for R1117X mutation, respectively. To examine whether such truncated 
SHANK3 proteins exist in the brain, we prepared postsynaptic density (PSD) fractions from 
striatal tissue and probed with antibodies recognizing epitopes located at either the N 
terminus (located upstream of both mutations) or C terminus of the SHANK3 protein 
(located downstream of both mutations; Table S1). When probed with the C terminus 
antibody, no signals above 75 kDa were detected in striatal PSD preparations from either 
homozygous InsG3680 mutant mice (InsG3680+/+) or R1117X mutant mice (R1117X+/+) 
(Figures 1C and 1D), consistent with the fact that the C terminus antibody recognizes 
epitopes that are beyond the premature stop codons caused by the InsG3680 and R1117X 
mutations. In contrast, when probed with an antibody raised against the N terminus of 
SHANK3 (Neuromab 367/62), we detected truncated SHANK3 bands in striatal PSD 
preparations from the R1117X mutant mice with the major band matching the predicted 122 
kDa expressed in HEK293 cells (Figure 1D). However, no clear signals were detected in 
striatal PSD preparations from InsG3680 mutant mice (Figure 1C). Similar results were 
obtained in PSD preparations from the cortex of R1117X and InsG3680 mutant mice using 
N terminus and C terminus antibodies. Together, our results reveal that R1117X and 
InsG3680 mutations have distinct effects on SHANK3 protein expression.
Since non-sense mutations could lead to reduced mRNA levels through non-sense-mediated 
decay (NMD) of abnormal mRNAs (Frischmeyer and Dietz, 1999), we examined Shank3 
mRNA levels in the striatum of InsG3680 and R1117X mutant mice by quantitative real-
time PCR. Due to the extensive alternative splicing of multiple coding exons in the Shank3 
gene (Wang et al., 2011b), we designed four pairs of primers probing different coding 
regions to minimize the potential detection bias caused by alternative splicing. We 
consistently observed dramatically reduced levels of Shank3 mRNA from striatal tissue of 
InsG3680+/+ mice with all four pairs of probes (Figures 1E–1H). Interestingly, striatal 
tissues from R1117X+/+ mice showed significantly higher levels of Shank3 mRNA than 
from InsG3680+/+ mice (Figures 1E–1H). These results suggest that Shank3 mRNAs with 
the R1117X mutation are more stable than mRNAs with the InsG3680 mutation, consistent 
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with our result that truncated SHANK3 proteins are present in R1117X+/+ mice. Together, 
our data suggest that the ASD-linked InsG3680 mutation results in an almost complete loss 
of SHANK3 protein, which is consistent with the full deletion of the SHANK3 gene 
identified in most Phelan-McDermid Syndrome patients (Bonaglia et al., 2011; Wilson et 
al., 2003). In contrast, the schizophrenia-linked R1117X mutation results in the generation 
of truncated SHANK3 protein, which could potentially either be partially functional or act in 
a dominant-negative form.
InsG3680 Mutants Exhibit Early Striatal Synaptic Transmission Defects and Impaired 
Social Interaction
Since ASD patients with SHANK3 mutations are usually diagnosed before the age of 3, 
whereas the schizophrenia patients carrying the R1117X mutation were diagnosed between 
ages 16 and 21, we wondered whether these two mutated mice exhibit any differential 
defects at early developmental stages. Since Shank3 is the only Shank family gene highly 
expressed in the striatum, we first examined the strength of evoked population spike 
responses in the striatum by performing field recordings in dorsolateral striatum at postnatal 
day 14 (P14). We found that InsG3680G+/+ mice have reduced field population spikes at 
postnatal day 14 (Figures 2A and 2B). In contrast, no difference was found between 
R1117X+/+ mice and their wild-type littermate controls (Figures 2D and 2E). Presynaptic 
function seems unaffected, as indicated by the relationship of stimulation intensity to 
amplitude of negative peak 1 (Figures 2C and 2F). We further measured other synaptic 
parameters including evoked AMPA to NMDA current ratio and miniature EPSCs by 
whole-cell patch-clamping recordings of dorsolateral striatal medium spiny neurons 
(MSNs). Through pharmacologically isolating evoked AMPA and NMDA current as 
described previously (Saal et al., 2003), we detected no change of AMPA to NMDA current 
ratio in both mutants as compared to their wild-type (Figure S1). No change of miniature 
EPSC (mEPSC) frequency was detected from both mutants as compared to wild-type 
controls (Figures 2G–2J). Interestingly, we observed significant increase of mEPSC 
amplitude in InsG3680+/+ mutants (Figures 2G and 2I), which may suggest a compensatory 
mechanism of MSNs in the presence of evoked synaptic transmission defects.
We next examined how the two mutations may affect the expression of synaptic proteins in 
the striatum at P14. We found significantly reduced Homer protein in both R1117X+/+ and 
InsG3680+/+ mice (Figure S2). Interestingly, we found that in the striatum of P14 
InsG3680+/+ mice, GluR1 is significantly upregulated, consistent with the increased AMPA-
mediated mEPSC amplitude observed. Several other synaptic proteins including SynGAP, 
Shank2, and NMDA receptor subunits also show a trend of upregulation (Figure S2). 
Together, our biochemistry data and electrophysiological measurements from evoked and 
basal synaptic transmission suggest a complex scenario in young InsG3680+/+ mice in which 
striatal-evoked population spike responses are reduced but basal AMPA receptor-mediated 
mEPSC amplitude and GluR1 are increased. This may suggest that at this developmental 
stage, MSNs are trying to compensate for the defective evoked synaptic transmission by 
upregulating AMPR receptors in remaining functional synapses.
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Although no basic synaptic transmission defects were detected in the striatum of P14 
R1117X+/+ mice, we found that PSD93, SynGAP, and NMDA receptor subunits are reduced 
in a striatal synaptosomal plasma membrane (SPM) preparation from these mice (Figure 
S2). Furthermore, unlike in the P14 InsG3680+/+ mice, we did not see a trend of 
upregulation of any of the synaptic proteins tested. Together, these data suggest that the 
truncated R1117X Shank3 protein might be partially functional and its presence is sufficient 
to maintain basic normal synaptic transmission. To test this hypothesis, we evaluated the 
ability of the R1117X Shank3 mutant to rescue previously characterized cortico-striatal 
synaptic dysfunction in our Shank3B knockout mice (Peça et al., 2011) by using a cortico-
striatal co-culture system. GFP plasmid alone or GFP plasmid together with R1117X 
Shank3 mutant plasmid were introduced into primary MSNs derived from Shank3B 
knockout mice through Nucleofection before plating. Transfected MSNs were then co-plated 
with cortical neurons. Whole-cell patch-clamp recordings of transfected neurons showed 
that expression of R1117X mutants significantly increased the frequency of mEPSCs in 
Shank3 knockout MSNs when compared to GFP control neurons (Figure S3). These in vitro 
data support the hypothesis that R1117X Shank3 mutant is partially functional in developing 
MSNs.
To evaluate the behavioral consequence caused by R1117X and InsG3680 Shank3 mutations 
at an early developmental stage, we first measured the maternal separation-induced 
ultrasonic vocalization behavior in pups between postnatal days 2 and 12. We found no 
significant differences in total number, total duration, mean duration, and peak amplitude of 
calls among genotypes. We next examined juvenile social play behavior at P23. We found 
significantly reduced numbers of all interactive events between mouse pairs carrying 
InsG3680+/+ mutation as compared to their wild-type littermate controls (Figure 2K). By 
categorizing the reciprocal play behavior into nose-to-nose, anogenital sniffing, and 
following behavior, we found both the nose-to-anogenital sniffing and following behavior 
are significantly reduced in InsG3680+/+ mice (Figure 2L). We found a similar trend in 
R1117X mice but it did not reach statistical significance (Figures 2M and 2N). Together, 
these data indicate an early-onset social interaction deficit in InsG3680+/+ Shank3 mutant 
mice.
Reduced Striatal Synaptic Transmission in Both Adult Mutant Lines
Although Shank3 is expressed in many brain regions, it is the only Shank family member 
enriched in the striatum. Our previous studies of young adult homozygous Shank3B 
knockout mice revealed significant synaptic defects in MSNs of the striatum including 
reduced pop spike responses by field recordings and reduced frequency and amplitude of 
miniature excitatory postsynaptic current (mEPSC) by whole-cell recordings (Peça et al., 
2011). Here we compared the effects of InsG3680 and R1117X mutations on striatal 
synaptic function using electrophysiological recording on acutely isolated brain slices. We 
found both InsG3680 and R1117X homozygous but not heterozygous mice showed reduced 
pop spike responses (Figures 3A, 3B, 3D, and 3E). No differences of presynaptic function 
were observed among all genotypes as indicated by similar NP1 response among genotypes 
(Figures 3C and 3F).
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We further measured the AMPA receptor-mediated mEPSCs by performing whole-cell 
patch-clamping recordings on dorsolateral striatal MSNs. We found that MSNs of both 
InsG3680 homozygous and heterozygous mice showed significant reduction of mEPSC 
frequency (Figures 3G and 3H). This reduction of mEPSC frequency was also observed in 
R1117X homozygous mice (Figures 3J and 3K). There is also a small but statistically 
significant reduction of mEPSC amplitude in MSNs from InsG3680+/+ and R1117X+/+ 
homozygous as well as R1117X+/− mice (Figures 3I and 3L). In addition, we found 
significantly reduced NMDA receptor-mediated currents in both R1117X+/+ and 
InsG3680+/+ as compared to their wild-type controls (Figure 4). Together, these results 
suggest that both InsG3680 and R1117X mutations cause significant synaptic dysfunction in 
the adult striatum.
Distinct Alteration of Synaptic Transmission in Prefrontal Cortex of R1117X Mutant Mice
Although pathological mechanisms of schizophrenia are still not known, numerous patient 
studies have implicated the dysfunction of prefrontal cortex (PFC) as an important 
pathogenic source in patients (Anderson et al., 1999). We found a significant reduction of 
mEPSC frequency in pyramidal neurons of mPFC in both R1117X+/− and R1117X+/+ 
mutant mice (Figures 5A and 5B). In addition, we observed a significant reduction of 
mEPSC amplitude in R1117X+/+ mice (Figure 5C). In contrast, no significant differences of 
either frequency or amplitude of mEPSC were found in InsG3680+/− or InsG3680+/+ mutant 
mice when compared to WT controls (Figures 5D–5F), although there is a trend of reduction 
in mEPSC frequency in InsG3680+/+ mutant mice. These results indicate that the R1117X 
mutation, but not the InsG3680 mutation, causes a profound deficit of synaptic transmission 
in mPFC.
One of the pathological findings in postmortem brains of schizophrenia patients is the 
reduction of spine density of layer 3 pyramidal neurons in the prefrontal cortex (Glantz and 
Lewis, 2000). To examine whether a similar defect exists in the two lines of Shank3 mutant 
mice, we used Golgi staining to measure the spine density of layer 2/3 pyramidal neurons in 
the frontal association area. We found a significant reduction of spine density in both 
R1117X heterozygous and homozygous mutant mice (Figures 5G and 5I). We also found a 
significant reduction of spine density in InsG3680 homozygous but not heterozygous mutant 
mice (Figures 5H and 5J).
All three SHANK family members are highly homologous and expressed in the cortex 
(Böckers et al., 2004; Lim et al., 1999; Peça et al., 2011). It has been reported that SHANK3 
was upregulated in Shank2 knockout mice (Schmeisser et al., 2012). Thus, it is possible that 
SHANK1-2 may be upregulated in Shank3 mutants to compensate for the loss of SHANK3. 
To explore this possibility, we quantified the expression level of Shank1 and Shank2 mRNA 
in the cortex of InsG3680+/+ and R1117X+/+ mutant mice. We found both Shank1 and 
Shank2 mRNAs were significantly upregulated in InsG3680+/+ but not R1117X+/+ mutant 
mice (Figures 5K and 5L), suggesting that the two mutations have differential effects on 
Shank1 and Shank2 mRNA upregulation. Furthermore, we observed significantly 
upregulated SHANK2 protein and a trend of increased SHANK1 protein in the cortex of 
InsG3680+/+ but not R1117X+/+ mutant mice (Figures 5M and 5N). However, we did not 
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observe upregulation of either mRNA or protein of Shank1 or Shank2 in the striatum of 
either mutant line. Together, these results suggest both mutation-specific and circuit-specific 
upregulation of other Shank family members, and the upregulation of SHANK1 and 
SHANK2 mRNAs and proteins in the cortex of InsG3680+/+ mutant mice may partially 
compensate for the loss of SHANK3 protein and thus alleviate synaptic defects in mPFC of 
InsG3680+/+ mutant mice.
Given the fact that patients carrying the schizophrenia-associated R1117X Shank3 mutation 
were diagnosed at their late adolescence stage (Gauthier et al., 2010), we examined whether 
there are synaptic defects in the mPFC of young mice (P14) from either mutant line. Similar 
to our findings in the mEPSC of adult InsG3680+/+ mice, we did not detect significant 
differences of either mEPSC frequency or amplitude in the mPFC of P14 InsG3680+/+ mice 
(Figures S4D–S4F). Interestingly, we detected a significant increase in mEPSC frequency in 
R1117X+/+ mice at P14 (Figures S4A–S4C), suggesting there is already some degree of 
aberrant synaptic connection/function in the mPFC region at this age, albeit different from 
adult defects.
We next examined synaptic protein expression in cortical SPM preparations at P14. As 
shown in Figure S4, we did not detect significant changes in synaptic protein levels except a 
small reduction of Homer protein in R1117X+/+ mice (Figure S4H). Interestingly, we 
observed a significant upregulation of Shank2 protein in InsG3680+/+ mice (Figure S4H), 
which we also observed in adult cortical SPM preparations of InsG3680+/+ mice (Figures 
5M and 5N). Together, these data indicate much minor molecular defects at cortical 
synapses at P14 in both lines.
Alteration of PSD Composition in Adult R1117X and InsG3680 Mutant Mice
The PSD95-SAPAP-SHANK scaffolding complex has been proposed to play important 
roles in the trafficking, assembly, and anchoring of signaling proteins to the PSD as well as 
in regulating the dynamic plasticity of the PSD (Sheng and Kim, 2011). Our previous 
studies showed that several scaffolding proteins and glutamate receptor subunits were 
reduced in the striatal PSD of Shank3B knockout mice (Peça et al., 2011). Here we 
examined levels of several scaffolding and signaling proteins as well as glutamate receptor 
subunits in the SPM of InsG3680+/+ and R1117X+/+ mutant mice. In an SPM preparation 
from striatal tissue, we found that Homer1b/c is dramatically reduced in both InsG3680+/+ 
and R1117X+/+ mutant mice (~14% of WT; Figures 6A and 6B). This is consistent with the 
fact that the Homer binding domain of Shank3 is located downstream of the premature stop 
codons caused by InsG3680 and R1117X mutation (Tu et al., 1999). Interestingly, we found 
that in InsG3680 and R1117X heterozygous mice, which has about 50% of full-length 
Shank3 protein, Homer protein is also reduced to 50% of the wild-type level (Figure S5), 
indicating the dependence of Homer synaptic localization on Shank3 and their one-to-one 
stoichiometry.
In general, we observed a very similar pattern of reduced synaptic protein in the striatal 
SPM of the two mutant lines. Syn-GAP1, PSD95, SAPAP3, NR1, NR2A, NR2B, and 
GluR2 are all either significantly reduced or have the similar trend of reduction in both 
mutant lines (Figures 6A–6C). However, a small reduction of mGluR5 protein was only 
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observed in the InsG3680+/+ line (Figures 6A and 6C). This correlates with the trend for 
impaired LTD maintenance 15~25 min after DHPG application compared to wild-type 
(Figure S6D) and mildly impaired PPR increase after DHPG-LTD in InsG3680+/+ (Figures 
S6G and S6H) but not R1117X+/+ mice (Figures S6C, S6E, and S6F). These data are 
consistent with our electrophysiological results showing severe striatal synaptic defects in 
adults of both mutant lines.
In the cortex, we found that Homer1b/c, PSD 95, and PSD 93 were significantly reduced in 
both InsG3680+/+ and R1117X+/+ mutant mice as compared to WT controls (Figures 6D and 
6E). Interestingly, the level of Homer1b/c reduction is slightly more significant in 
R1117X+/+ mutant mice than in InsG3680+/+ mice (Figure 6E). In addition, we observed 
significant reduction of NR1 and its close interacting partner SynGAP1 only in the 
R1117X+/+ mutant mice (Figures 6D–6F), in line with previous findings using postmortem 
cortex tissue from schizophrenia patients (Funk et al., 2009; Weickert et al., 2013). 
Together, these data indicate that although cortical synaptic transmission defects are very 
different in the adults of the two mutant lines, differences in molecular defects are not as 
dramatic, raising the possibility that developmental defects in connectivity may contribute 
significantly to observed synaptic transmission and behavioral defects.
InsG3680 and R1117X Mutant Mice Show Both Common and Differential Behavioral 
Phenotypes
As described above, our molecular and electrophysiological studies of InsG3680 and 
R1117X mutant mice showed that they have both shared and distinct synaptic defects. We 
next tested whether these synaptic defects are accompanied by behavioral changes. We 
found that both R1117X+/+ and InsG3680+/+ mice show significantly reduced explorative 
activity in an open field arena (total distance) when compared to wild-type littermates 
(Figures 7A and 7B). In addition, InsG3680+/− mice also showed significantly reduced 
activity (Figure 7A). Both lines of mutant mice show a very similar habituation time course 
compared to their wild-type littermates (Figures S7A and S7B), suggesting that the reduced 
explorative activity is caused by reduced locomotion rather than faster habituation of mutant 
mice. These reduced locomotion and hypoactive features in mutant mice were further 
supported by rotarod test findings showing that both R1117X+/+ and InsG3680+/+ Shank3 
mice have impaired motor learning and coordination capability (Figures S8A and S8B).
In addition to the hypoactive phenotype, both R1117X and InsG3680 Shank3 mutant mice 
spent much less time exploring the center in an open area test compared to wild-type 
littermates (Figures S7C and S7D), suggesting an anxiety-like behavior. In the elevated zero 
maze test, we found that both R1117X+/+ and InsG3680+/+ mice spent much less time in the 
open arms as compared to their wild-type littermates (Figures 7C and 7D). In addition, 
heterozygous mutants from both lines also spent less time in the open arms as compared to 
their wild-type littermates (Figures 7C and 7D). These results indicate that both R1117X and 
InsG3680G mutant mice exhibit increased levels of anxiety.
Pre-pulse inhibition (PPI) is commonly used to test sensorymotor gating function in animal 
models of schizophrenia, although defects in PPI are not specific to schizophrenia and are 
present in many other psychiatric disorders, both in patients and animal models (Swerdlow 
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et al., 1993; Joober et al., 2002). We found that both R1117X+/+ and InsG3680+/+ mice 
show profound defects in acoustic startle response (Figures S8C and S8D). Thus, although 
we found significantly reduced PPI in InsG3680+/+ and slightly impaired PPI in R1117X+/+ 
mice (Figures S8E and S8F), the interpretation of these data is complicated by the 
significant defects in startle response, because any PPI results are primarily confounded by a 
decrease in absolute startle to a 120 dB auditory stimulus. In addition, we found no 
difference in performance in the T maze spontaneous alternation test between wild-type and 
either line of mutant mice, suggesting normal basic working memory in both lines of mutant 
mice.
Since impaired social interaction is one of the core features of ASD patients and social 
withdraw is a characteristic negative symptom in schizophrenia patients, we tested social 
interactions of R1117X and InsG3680 mutant mice with a slightly modified standard three 
chamber social interaction paradigm (Chao et al., 2010; Silverman et al., 2010). As 
expected, wild-type mice showed significant preference for strange mouse (S1) to a novel 
object (O) (Figures 7E and 7F). However, both InsG3680 and R1117X homozygous mutant 
mice showed no significant preference for other mice compared to the novel object side 
(Figures 7E and 7F). Interesting, heterozygous R1117X mutant mice, but not heterozygous 
InG3680 mutant mice, also displayed social interaction deficits (Figure 7F). Similarly, in the 
social novelty test, both homozygous and heterozygous R1117X mutant mice exhibited 
deficits, while only homozygous InsG3680 mutant mice showed the defect (Figures 7G and 
7H). Together, these results demonstrated that both the InsG3680 mutation and R1117X 
mutation lead to social interaction deficits, similar to Shank3 mutant mice with deletion of 
either the ankyrin repeats or PDZ domain (Peça et al., 2011; Wang et al., 2011b).
Repetitive behavior/restricted interest is another key feature of ASD. Several mouse models 
of psychiatric disorders including ASD, OCD, and Tourette syndrome show repetitive 
grooming phenotypes and some of them develop skin lesions due to overgrooming 
(Karayannis et al., 2014; Peça et al., 2011; Rothwell et al., 2014; Welch et al., 2007). These 
repetitive/compulsive-like behaviors have been strongly linked to cortico-striatal-thalamo-
cortical circuitry dysfunction (Ahmari et al., 2013; Burguière et al., 2013; Peça et al., 2011; 
Rothwell et al., 2014; Shmelkov et al., 2010; Welch et al., 2007). In our breeding colony, we 
found that 28.1% (18/64) of InsG3680+/+ mice develop lesions between 4 and 6 months of 
age (Figure 8A), a similar rate to our previous finding in Shank3B knockout mice (Peça et 
al., 2011). In contrast, only 8.7% (6/69) of R1117X+/+ mice developed skin lesions at the 
same age. Statistical analysis of lesion penetrance using chi-square test revealed significant 
difference between R1117X+/+ and InsG3680+/+ mice (p = 0.0036). No skin lesions were 
found in R1117X+/−, InsG3680+/− and wild-type groups. We next quantified the percentage 
of time R1117X and InsG3680 mice spent on grooming during a 2-hr session. We found that 
InsG3680+/+ mice spend twice as much time on grooming when compared to their WT 
littermates (Figure 8B), and a similar degree of increase in grooming time was also observed 
during the social interaction test. In contrast, R1117X+/+ mice did not show a statistically 
significant increase in grooming time compared to their WT littermates (Figure 8C), 
although a trend of increase was observed. These results suggest that only InsG3680+/+ mice 
show robust repetitive/compulsive grooming behavior.
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In our R1117X+/− × WT mating cages, we frequently observed partial or complete facial 
hair loss of WT mice without any lesions, suggesting allogrooming/barbering by R1117X+/− 
mice (Figure 8D). We confirmed that loss of whisker and facial hair was caused by 
allogrooming by a cage mate instead of selfgrooming by separating the mating pairs with the 
phenotype. We observed nearly full regrowth of facial hairs after weeks of single housing. 
Furthermore, pairing the recovered animals with their original cagemates induced robust 
loss of whisker and facial hair again within 2 weeks (data not shown). This allogrooming/
barbering phenotype also occurred in R1117X+/− × R1117X+/− mating cages, in which one 
of the R1117X+/− mice and/or offspring would lose their facial hair. We observed 
allogrooming/barbering in 48% (14 of 29) mating cages with R1117X+/− mice. In contrast, 
we only observed allogrooming/barbering phenotype in 14% (5 of 37) mating cages with 
InsG3680+/− mice. Analysis of allogrooming phenotype penetrance using chi-square test 
revealed a significant difference between R1117X+/− and InsG3680+/− mice (p = 0.002). 
These results suggest that R1117X and InsG3680 mutations have differential effects on the 
expression of allogrooming/barbering phenotype.
Previous studies in rodents have implicated the impairment of PFC function in 
allogrooming/social dominance (Jiang-Xie et al., 2014; Wang et al., 2011a). Our 
electrophysiological findings from mPFC indicated that both R1117X+/− and R1117X+/+ 
have profound deficits of synaptic transmission (Figures 5A–5C). To further evaluate the 
social dominance phenotype, we performed standard tube test (Figure 8E) between wild-
type versus heterozygous and wild-type versus homozygous mice in the two mutant lines. 
When the two stranger mice meet in the middle of the tube, the dominant mouse will 
advance and drive the other mouse out of the tube (Wang et al., 2011a). We found that both 
R1117X+/+ and R1117X+/− mice show much higher probability of winning the matches 
when tested with their wild-type opponents (Figure 8F). We also observed a significantly 
increased winning percentage in InsG3680+/+ but not in InsG3680+/− mice against their 
wild-type opponents (Figure 8G). These results are consistent with our electrophysiological 
and morphological findings in the prefrontal cortex showing synaptic deficits in both 
heterozygous and homozygous mice with R1117X mutation but only in homozygous mice 
with InsG3680 mutation.
DISCUSSION
Although schizophrenia and autism are two differential disorders based on 
phenomenological diagnosis (DSM-5), it has long been recognized that they share some 
common features and comorbidity (de Lacy and King, 2013; King and Lord, 2011). This is 
particularly true between child onset schizophrenia and autism (Meyer et al., 2011; Rapoport 
et al., 2009). For example, in a recent study, out of 46 schizophrenia patients with normal 
intelligence, about 50% met the diagnostic criteria of ASD (Unenge Hallerbäck et al., 2012). 
Recent human genetic studies have provided strong biological support for these clinical 
findings. GWAS, CNV, and exome sequencing have all identified many of the same genes 
in both disorders (Lee et al., 2013; Cross-Disorder Group of the Psychiatric Genomics 
Consortium, 2013; Krystal and State, 2014). Despite strong clinical and genetic evidence, 
however, it is not clear how different mutations of the same gene may contribute to different 
disorders. In this study, we generated new mouse models that harbor the highly penetrant 
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SHANK3 mutations found in ASD and schizophrenia patients. Our study revealed both 
distinct and shared defects in the two lines of mutant mice at molecular, synaptic, circuit, 
and behavioral levels (summarized in Table S2). Our results may provide, for the first time, 
some neurobiological insights on how different mutations in the SHANK3 gene may lead to 
mutation-specific defects and relevant behavior abnormalities.
Early Synaptic Transmission Defects in the Striatum of Mice with ASD-Associated 
Mutation
One of our interesting findings is that mice with the ASD-associated InsG3680 mutation 
exhibit earlier synaptic transmission defects when compared with mice with the 
schizophrenia-associated R1117X mutation. We found a reduction of population spike 
responses in P14 InsG3680+/+ mutant mice, indicating defects in evoked striatal synaptic 
transmission. The lack of obvious presynaptic defects suggests that there are fewer 
functional synapses in these mutant mice. Interestingly, we found a surprising increase of 
GluR1 protein and mEPSC amplitude in striatal MSNs from P14 InsG3680+/+ mutant mice. 
Along with the trend of upregulation of many other synaptic proteins (Shank2, SynGAP, 
NR1, and NR2) in the striatum of P14 InsG3680+/+ mutant mice, this may reflect a potential 
compensatory mechanism by the remaining functional synapses to counteract defects in 
evoked synaptic transmission.
A puzzling finding in P14 striatum of R1117X mutant mice is the reduction of PSD93, 
SynGAP, NR1, NR2A, and NR2B proteins but normal basic synaptic transmission including 
population spike responses, AMPA/NMDA ratio, mEPSC frequency, and amplitude. We do 
not have a clear answer regarding this discrepancy between the electrophysiological and 
biochemical findings. One possible explanation is that the remaining truncated R1117X 
Shank3 protein is partially functional in MSNs at this developmental stage, as suggested by 
our study in cultured neurons, and its presence is sufficient to maintain a basic level of 
synaptic transmission. However, it is also highly possible that striatal synaptic transmission 
in R1117X+/+ mutant mice at P14 is already mildly dysregulated and more extensive studies 
may reveal defects of other synaptic parameters.
Distinct Prefrontal Cortex Defects in R1117X Mutant Mice
Currently, the pathological mechanisms underlying schizophrenia are not well understood. 
However, clinical studies from human patients have implicated the dysfunction of prefrontal 
cortex (PFC), in particular dorsolateral prefrontal cortex (dlPFC), as an important cause of 
deficits in working memory, executive function, and social impairment (Anderson et al., 
1999; Euston et al., 2012). In addition, postmortem studies have revealed reduced numbers 
of dendritic spines in pyramidal neurons of dlPFC region from schizophrenia patients 
(Glantz and Lewis, 2000). Rodents do not have an anatomically distinct dlPFC (Uylings et 
al., 2003). However, electrophysiological and behavioral studies suggest that medial 
prefrontal cortex (mPFC) in rodents may perform some equivalent functions to primate 
dlPFC at a rudimentary level (Seamans et al., 2008), such as working memory, decision 
making, and social interaction (Adhikari et al., 2010; Amodio and Frith, 2006; Wang et al., 
2011a). Consistent with these findings, our study revealed profound synaptic transmission 
defects in mPFC of mice with the schizophrenia-associated R1117X mutation, but not with 
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the ASD-associated InsG3680 mutation, indicating that these two mutations affect distinct 
circuits.
Since all three members of the Shank family genes are expressed in the cortex (Böckers et 
al., 2004; Lim et al., 1999; Peça et al., 2011), it is possible that they may have functional 
redundancy to compensate for the loss of other members. Very interestingly, we found that 
upregulation of Shank1 and Shank2 happens only in the cortex of InsG3680 mutants but not 
in R1117X mutants. The upregulation of Shank1-2 in the cortex of InsG3680 mutants may 
compensate for the loss of SHANK3 and thus alleviate synaptic defects. In addition, the 
truncated SHANK3 protein resulting from the R1117X mutation may have a dominant-
negative effect, preventing SHANK1 and/or SHANK2, expressed at normal level, from 
assembling into the postsynaptic signaling complex. Such a dominant-negative effect would 
prevent compensation by Shank1 and Shank2 in R1117X mutants. Interestingly, Shank1 and 
Shank2 are normally not highly expressed in the striatum (Peça et al., 2011) and we did not 
observe upregulation of Shank1 and Shank2 in the striatum of either mutant line. Thus, 
upregulation and compensation by Shank1 and Shank2 is not only mutation specific, but also 
cell type/brain region specific, adding another layer of complexity to the study of 
neurobiological mechanisms underlying genetically overlapping psychiatric disorders.
Commonality and Differences in Behavioral Phenotypes
One of the most common phenotypes in mouse models with mutations of ASD risk genes is 
repetitive behavior, and previous studies have strongly linked repetitive/compulsive 
behaviors to defects in cortico-striatal-thalamo-cortical (CSTC) circuits (Burguière et al., 
2013; Peça et al., 2011; Rothwell et al., 2014; Shmelkov et al., 2010; Welch et al., 2007). 
Similar to our reported Shank3B knockout mice, the repetitive/compulsive grooming 
behaviors in InsG3680 mutant mice are very robust. R1117X mutant mice do not show 
significant repetitive grooming behavior, although both mutant lines show striatal molecular 
and synaptic defects. There are several possible explanations for this phenotypic difference. 
First of all, the striatum is only one part of the CSTC circuit, and differential defects in other 
parts of the brain, such as the cortex, may significantly affect the behavioral output. Second, 
recent studies have begun to reveal specific changes in subcircuits/microcircuits of the 
CSTC that may underlie repetitive behaviors, and the two mutations may differentially 
affect these sub-circuits/micro-circuits. Finally and probably most importantly, striatal 
synaptic transmission defects at early developmental stages in InsG3680 mutants may lead 
to long-lasting alterations in striatal connectivity. These connectivity defects may lead to 
InsG3680-specific circuit dysfunction and overgrooming even though synaptic transmission 
defects are similar between the two mutant lines in adults.
A behavioral phenotype predominantly found in R1117X mutants is the allogrooming and 
social dominance behavior. Although the exact mechanisms/circuits involved in dominance 
behaviors in mice are still not well understood, recent studies have provided evidence 
implicating mPFC in social dominance (Lin et al., 2011; Wang et al., 2014a). Our studies 
demonstrated significant synaptic transmission defects in the mPFC of R1117X, but not 
InsG3680 mutant mice. These correlative data may provide a partial explanation for the 
difference in social dominance behavior between these two mutant lines.
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Previous studies have demonstrated that two different mutations of the MECP2 gene in Rett 
Syndrome patients differentially affect the function of a key domain in MeCP2 and result in 
different severity of phenotypes in mice similar to the disease progression and symptoms 
observed in patients with these two mutations (Baker et al., 2013). Although it is difficult to 
directly correlate mouse behaviors with patient symptoms and diagnosis, our study at least 
provides neurobiological evidences and mechanisms that the two SHANK3 mutations 
associated with ASD and schizophrenia cause both common and differential defects at 
molecular, synaptic, and behavioral levels. More broadly, we demonstrated that different 
mutations of the same gene may elicit neurobiological changes at different developmental 
stages, brain regions, and cell types through a variety of potential mechanisms including 
differential mRNA stability, differential regulation of compensatory gene expression, and 
different degrees of signaling complex disruption. Thus, future detailed analysis of such 
mutations will help to gain a more precise understanding of synaptic development and 
function.
EXPERIMENTAL PROCEDURES
Animal Work Statement
All animal-related work was performed under the guidelines of Division of Comparative 
Medicine (DCM), with protocol (# 0513-044-16 of Feng laboratory and #1012-102-15 of 
Lewis laboratory) approved by Committee for Animal Care (CAC) of Massachusetts 
Institute of Technology and was consistent with the Guide for Care and Use of Laboratory 
Animals, National Research Council 1996 (institutional animal welfare assurance no. 
A-3125-01). Only aged-matched male mice were used for all behavioral experiments; all 
other tests included age-matched males and females in proportional contribution across 
groups.
Behavioral Studies
All behavioral studies were carried out and analyzed with experimenter blinded to genotype. 
For all assays, mice were habituated in the test facility for 1 hr prior to starting the task. 
Each cohort of mice was used for maximally three behavioral tests with at least 5 days’ 
break between tasks.
Electrophysiological Recordings
All electrophysiological measurements were performed and analyzed with experimenter 
blinded to genotype.
Data Analysis
All comparisons between groups were collected from littermate animals with experiments 
performed at the same time. All results were presented as mean ± SEM and were analyzed 
statistically using Student’s t test, one-way or two-way analysis of variance with proper post 
hoc test as specified in legend of each figure (GraphPad Prism, RRID: rid_000081, 
SCR_002798). *p < 0.05; **p < 0.01; ***p < 0.001.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Major psychiatric disorders share many risk genes
• Two mouse lines with ASD-linked and schizophrenia-linked mutations were 
studied
• Two mutant lines show both shared and distinct synaptic and behavioral 
phenotypes
• Both developmental and molecular differences were detected in the two mutant 
lines
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Figure 1. Genetically Engineered Mice with InsG3680 or R1117X Shank3 Mutation 
Differentially Express SHANK3 Protein and mRNA
(A) Schematic diagram for wild-type Shank3-, InsG3680-, and R1117X-targeted Shank3 
alleles. Gene structure of wild-type mouse Shank3 gene and magnified panels on the 
structure between exon 20 and exon 22 are shown below. Top: wild-type Shank3; middle: 
autism-associated InsG3680 Shank3 mutation with an insertion of “guanine” nucleotide at 
position 3680; bottom: schizophrenia-associated R1117X Shank3 mutation changing the 
“CGG” codon for arginine to a “TGA” stop codon.
(B) Representative sequencing chromatograms of wild-type and InsG3680 mutated alleles; 
wild-type and R1117X mutated alleles showing the point mutations.
(C) Representative western blots using striatal PSD fractions prepared from wild-type, 
Shank3B KO mice, InsG3680+/− mice, InsG3680+/+ mice; lysate from HEK239 cells 
expressing cDNA plasmid encoding the InsG3680 mutated Shank3. Note that neither the 
antibody against the N nor C terminus detected SHANK3 protein in InsG3680+/+ mice.
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(D) Representative western blots using striatal PSD fractions prepared from wild-type, 
Shank3B KO mice, R1117X+/− mice, R1117X+/+ mice; lysate from HEK239 cells 
expressing cDNA plasmid encoding the R1117X mutated Shank3. Note that SHANK3 
protein expression is almost abolished except for a prominent truncated isoform in the 
R1117X+/+ line that is detected with the antibody against the N terminus.
(E–H) The relative level of Shank3 mRNA in striatum is different between the two lines as 
quantified by primers amplifying exon 1 to 2, exon 6 to 8, 16 to 17, and partial exon 21 
before both Shank3 mutation sites. Data are normalized to Gapdh mRNA and presented as 
mean ± SEM. **p < 0.01, ***p < 0.001; one-way ANOVA with Bonferroni post hoc test, 
WT mice (n = 5), R1117X+/+ mice (n = 5) and InsG3680+/+ mice (n = 5).
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Figure 2. InsG3680+/+ but Not R1117X+/+ Mice Display Altered Striatal Synaptic Transmission 
at P14 and Reduced Social Interaction at P23
(A and D) Representative cortico-striatal pop spike traces recorded from P14 mice with 
indicated genotypes.
(B and C) Cortical-striatal input-output curve shows reduced pop spike responses in 
InsG3680+/+ mice compared to wild-type littermates. NP1 amplitude is similar between the 
genotypes, suggesting that presynaptic input is not different.
(E and F) Cortical-striatal input-output curve shows similar pop spike responses and NP1 
amplitude between R1117X+/+ mice and their wild-type littermates. In (B), (C), (E), and (F), 
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data are presented as mean ± SEM. *p < 0.05; two-way ANOVA repeated-measures with 
Bonferroni post hoc test. n = 12 slices from 4 pairs of littermates for each cohort.
(G and H) Typical AMPA receptor-mediated mEPSC traces recorded from P14 MSNs with 
indicated genotypes.
(I and J) Amplitude but not frequency of mEPSC is increased in InsG3680+/+ MSNs 
compared to wild-type. No change of amplitude or frequency of mEPSC in R1117X+/+ 
MSNs. In InsG3680 cohort, n = 29 neurons for wild-type; n = 29 neurons for InsG3680+/+ 
from 3 pairs of littermates; in R1117X cohort, n = 30 neurons for wild-type, n = 31 neurons 
for R1117X+/+ from 3 pairs of littermates. Data are presented as mean ± SEM; two-tailed t 
test.
(K and M) Total number of interaction events from mice pairs with indicated genotypes as 
normalized to wild-type control.
(L and N) Normalized number of categorized interaction events from mice pairs with 
indicated genotypes as normalized to wild-type control.
In (K), (L), (M), and (N), in R1117X cohort, n = 9 pairs of mice for wild-type; n = 9 pairs of 
mice for R1117X+/+; in InsG3680 cohort, n = 8 pairs of mice for wild-type; n = 10 pairs of 
mice for InsG3680+/+. Data are presented as mean ± SEM, *p < 0.05, **p < 0.01; two-tailed 
t test.
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Figure 3. Striatal Synaptic Transmission Is Reduced in Adult R1117X and InsG3680 Mutant 
Mice
(A and D) Representative cortical-striatal pop spike traces from mice with indicated 
genotypes.
(B and E) Reduced striatal pop spike amplitude in both InsG3680+/+ and R1117X+/+ mice.
(C and F) No difference of NP1 amplitude among genotypes.
In (B), (C), (E), and (F) data are presented as mean ± SEM. ***p < 0.001; two-way 
ANOVA repeated-measures with Bonferroni post hoc test. n = 12 slices per genotype from 4 
pairs of mice.
(G and J) Typical AMPA receptor-mediated mEPSC traces recorded from MSNs with 
indicated genotypes.
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(H and I) mEPSC frequency of MSNs is reduced in both homozygous and heterozygous 
InsG3680 mutant mice compared to wild-type littermates. mEPSC amplitude is also reduced 
in homozygous InsG3680 mutant mice. n = 26 neurons for WT; n = 24 neurons for 
InsG3680+/−; n = 21 neurons for InsG3680+/+ from three pairs of mice.
(K and L) mEPSC frequency of MSNs is reduced in homozygous R1117X mutant mice 
compared to wild-type littermates. mEPSC amplitude is reduced in both homozygous and 
heterozygous R1117X mutant mice. n = 23 neurons for WT; n = 24 neurons for R1117X+/−; 
n = 26 neurons for R1117X+/+ from three pairs of mice. In (H), (I), (K), and (L), data are 
presented as mean ± SEM. **p < 0.01, ***p < 0.001; one-way ANOVA with Bonferroni 
post hoc test.
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Figure 4. Reduced NMDA Receptors Mediated Synaptic Transmission in Both R1117X+/+and 
InsG3680+/+ Shank3 Mutant Mice
(A–C) Typical NMDA receptors mediated currents from striatal MSNs by stimulating 
corpus callosum and quantification. n = 16 neurons for wild-type; n = 18 neurons for 
R1117X+/+ from three pairs of littermates at 7 week’s age.
(D–F) Typical NMDA receptors mediated currents from striatal MSNs by stimulating 
corpus callosum and quantification. n = 14 neurons for wild-type; n = 12 neurons for 
InsG3680+/+ from three pairs of littermates at 8 week’s age. In both (C) and (F), data are 
presented as mean ± SEM. *p < 0.05; two-way ANOVA test.
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Figure 5. Profound Cortical Synaptic Defects Manifest in Mice Carrying the Schizophrenia-
Associated R1117X Mutation
(A–C) Typical AMPA receptor-mediated mEPSC recordings in the prefrontal cortex and 
statistical results for R1117X mice. n = 13 neurons for WT; n = 20 neurons for R1117X+/−; 
n = 18 neurons for R1117X+/+ from three pairs of mice. Note the highly significant 
reduction of mEPSC frequency in both heterozygous and homozygous mice and a modest 
reduction of amplitude in homozygotes.
(D–F) Typical AMPA receptor-mediated mEPSC recordings in the prefrontal cortex and 
statistical results for InsG3680 cohort. n = 18 neurons for WT; n = 16 neurons for 
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InsG3680+/−; n = 17 neurons for InsG3680+/+ from three pairs of mice. Both heterozygous 
and homozygous mice display comparable miniature events to wild-type mice.
In (B), (C), (E), and (F), data are presented as mean ± SEM. *p < 0.05, **p < 0.01; one-way 
ANOVA with Bonferroni post hoc test.
(G and H) Representative confocal images of secondary dendrites of pyramidal neurons 
from frontal association area of mice with indicated genotypes (scale bar, 10 μm).
(I and J) Quantification of spine number from neurons with indicated genotypes from three 
littermate pairs indicates reduced spine numbers in R1117X+/−, R1117X+/+, and 
InsG3680+/+ mice.
(K and L) mRNAs of Shank3 homologs Shank1 and Shank2 are upregulated in cortical 
tissue from InsG3680+/+ compared to wild-type mice. Data are normalized to Gapdh mRNA 
and presented as mean ± SEM. WT mice (n = 5), R1117X+/+ mice (n = 5), and InsG3680+/+ 
mice (n = 5). In all the panels, data were collected from 2-month-old mice. In (I), (J), (K), 
and (L), *p < 0.05, **p < 0.01, **p < 0.001; one-way ANOVA with Bonferroni post hoc 
test.
(M) Representative blots for proteins detected by specific antibodies in the cortical SPM 
fraction from adult wild-type, R1117X+/+, and InsG3680+/+ mice.
(N) Adult InsG3680+/+ but not R1117X+/+ mice show increased Shank2 expression in 
cortical tissue. Quantification of relative levels of proteins as normalized to tubulin from 
cortical SPM. Data are presented as mean ± SEM *p < 0.05; one sample t test. (n = 8 
samples per protein per genotype, each n being pooled tissue from two mice).
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Figure 6. InsG3680 and R1117X Mutant Mice Display Common and Differential Disruptions of 
Post-synaptic Signaling Complexes
(A) Representative blots for proteins detected by specific antibodies in the striatal SPM 
fraction from wild-type, InsG3680+/+, and R1117X+/+ mice.
(B and C) Quantification of relative levels of proteins as normalized to tubulin protein 
expression from striatal SPM. (n = 4–6 samples per protein per genotype, each n being 
pooled tissue from three mice).
(D) Representative blots for proteins detected by specific antibodies in the cortical SPM 
fraction from wild-type, InsG3680+/+, and R1117X+/+ mice.
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(E and F) Quantification of relative levels of proteins as normalized to tubulin protein 
expression from cortex SPM. (n = 4–11 samples per protein per genotype, each n being 
pooled tissue from two mice).
In (B), (C), (E), and (F), data are presented as mean ± SEM. *p < 0.05, **p < 0.01, **p < 
0.001; one sample t test.
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Figure 7. InsG3680 and R1117X Mutant Mice Display Anxiety Behavior and Social Interaction 
Deficits
(A and B) Total distance traveled in the open field test as normalized to wild-type 
littermates.
(C and D) Time spent in the open arms in the elevated zero maze test as normalized to wild-
type littermates.
In the InsG3680 cohort, n = 17 mice for wild-type; n = 19 mice for InsG3680+/−; n = 18 
mice for InsG3680+/+ group. In the R1117X cohort, n = 15 mice for wild-type, n = 15 mice 
for R1117X+/−; n = 15 mice for R1117X+/+.
(E and F) Time spent on close interaction with an object (O) versus stranger mice (S1) in the 
phase II social interaction test.
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(G and H) Time spent on close interaction with a familiar mouse (S1) versus stranger mouse 
(S2) in the phase III social interaction test.
In the InsG3680 cohort, n = 17 mice for wild-type; n = 19 mice for InsG3680+/−; n = 18 
mice for InsG3680+/+ group; in the R1117X cohort, n = 23 for wild-type, n = 25 for 
R1117X+/−; n = 24 for R1117X+/+ group.
In all the panels, data are presented as mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001; 
one-way ANOVA with Bonferroni post hoc test.
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Figure 8. InsG3680 Mice Show More Profound Repetitive Self-Grooming, whereas R1117X Mice 
Display Allogrooming and Dominance-like Behavior
(A) Representative pictures from an adult wild-type and an InsG3680+/+ mouse that 
developed a lesion in the head/neck area.
(B and C) Time spent on grooming during 2 hr videotaping of indicated genotypes as 
normalized to their wild-type littermates. In the InsG3680 cohort, n = 9 mice for wild-type; 
n = 9 mice for InsG3680+/−; n = 10 mice from InsG3680+/+ group. In the R1117X cohort, n 
= 9 mice for wild-type, n = 9 mice for R1117X+/−; n = 9 mice for R1117X+/+. Data are 
presented as mean ± SEM. *p < 0.05; Kruskal-Wallis test with Dunn’s post hoc comparison.
(D) Representative pictures of an R1117X+/− mouse with intact facial hair and a wild-type 
mouse shaved by its cage mate as an indication for allogrooming behavior.
(E) Diagram of tube test task between two unfamiliar mice with different genotypes.
(F and G) Percentage of wins in test pairs between indicated genotypes, 11/18 (61%) of 
R1117X+/− versus WT; 16/18 (89%) of R1117X+/+ versus WT; 6/14 (43%) of InsG3680+/− 
versus WT; 8/11 (73%) of InsG3680+/+ versus WT. Note that both R1117X+/− and 
R1117X+/+ mice perform significantly above chance level. One-sample chi-square test was 
used to determine the significant difference. “*” indicates significantly different from an 
expected chance (50:50 win-lose outcome).
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